Literature DB >> 7918358

Sequential 1H, 13C, and 15N NMR assignments and solution conformation of apokedarcidin.

K L Constantine1, K L Colson, M Wittekind, M S Friedrichs, N Zein, J Tuttle, D R Langley, J E Leet, D R Schroeder, K S Lam.   

Abstract

Kedarcidin is a recently discovered antitumor antibiotic chromoprotein. The solution conformation of the kedarcidin apoprotein (114 residues) has been characterized by heteronuclear multidimensional NMR spectroscopy. Sequence-specific backbone atom resonance assignments were obtained for a uniformly 13C/15N-enriched sample of apokedarcidin via a semiautomated analysis of 3D HNCACB, 3D CBCA-(CO)NH, 4D HNCAHA, 4D HN(CO)CAHA, 3D HBHA(CO)NH, and 3D HNHA(Gly) spectra. Side-chain assignments were subsequently obtained by analysis of (primarily) 3D HCCH-TOCSY and HCCH-COSY spectra. A qualitative analysis of the secondary structure is presented on the basis of 3J alpha NH coupling constants, deviations of 13C alpha and 13C beta chemical shifts from random coil values, and NOEs observed in 3D 15N- and 13C-edited NOESY-HSQC spectra. This analysis revealed a four-stranded antiparallel beta-sheet, a three-stranded antiparallel beta-sheet, and two two-standed antiparallel beta-sheets. The assignments of cross-peaks in the 3D NOESY spectra were assisted by reference to a preliminary model of apokedarcidin built using the program CONGEN starting from the X-ray structure of the homologous protein aponeocarzinostatin. An ensemble of 15 apokedarcidin solution structures has been generated by variable target function minimization (DIANA program) and refined by simulated annealing (X-PLOR program). The average backbone atom root-mean-square difference between the individual structures and the mean coordinates is 0.68 +/- 0.08 A. The overall fold of apokedarcidin is well-defined; it is composed of an immunoglobulin-like seven-stranded antiparallel beta-barrel and a subdomain containing two antiparallel beta-ribbons. Highly similar tertiary structures have been previously reported for the related proteins neocarzinostatin, macromomycin, and actinoxanthin. Important structural features are revealed, including the dimensions of the chromophore-binding pocket and the locations of side chains that are likely to be involved in chromophore stabilization.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7918358     DOI: 10.1021/bi00204a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  6 in total

1.  Key interactions in the immunoglobulin-like structure of apo-neocarzinostatin: evidence from nuclear magnetic resonance relaxation data and molecular dynamics simulations.

Authors:  N Izadi-Pruneyre; Y Blouquit; J Perez; P Minard; M Desmadril; J Mispelter
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

2.  Assignment of aliphatic side-chain 1HN/15N resonances in perdeuterated proteins.

Authors:  B T Farmer; R A Venters
Journal:  J Biomol NMR       Date:  1996-01       Impact factor: 2.835

3.  Protein phi and psi dihedral restraints determined from multidimensional hypersurface correlations of backbone chemical shifts and their use in the determination of protein tertiary structures.

Authors:  R D Beger; P H Bolton
Journal:  J Biomol NMR       Date:  1997-09       Impact factor: 2.835

4.  Cloning and sequencing of the kedarcidin biosynthetic gene cluster from Streptoalloteichus sp. ATCC 53650 revealing new insights into biosynthesis of the enediyne family of antitumor antibiotics.

Authors:  Jeremy R Lohman; Sheng-Xiong Huang; Geoffrey P Horsman; Paul E Dilfer; Tingting Huang; Yihua Chen; Evelyn Wendt-Pienkowski; Ben Shen
Journal:  Mol Biosyst       Date:  2013-01-29

5.  Affinity transfer by CDR grafting on a nonimmunoglobulin scaffold.

Authors:  Magali Nicaise; Marielle Valerio-Lepiniec; Philippe Minard; Michel Desmadril
Journal:  Protein Sci       Date:  2004-05-28       Impact factor: 6.725

Review 6.  Samarium(ii) iodide-mediated reactions applied to natural product total synthesis.

Authors:  Majid M Heravi; Azadeh Nazari
Journal:  RSC Adv       Date:  2022-03-30       Impact factor: 3.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.